Clinical Trials in Los Angeles

Showing 15341-15360 of 16,901 trials

An Open Label Extension Study of STX209 in Subjects With Autism Spectrum Disorders

NCT01064973

Study 22003, "An Open-Label, Flexible-Dose Evaluation of the Safety and Tolerability of STX209 for Treatment of Irritability in Subjects With Autism Spectrum Disorders(ASD)" currently is evaluating the efficacy of STX209 (R-baclofen) for management of typical problem behaviors, such as irritability and aggression, in subjects with ASD. This study (22007) will enter subjects who complete Study 22003 into a long-term, open-label study.The open-label extension protocol will provide necessary data on the long-term safety and tolerability of STX209 among subjects with ASD who receive treatment under conditions more closely reflective of their general medical care.

Autism Spectrum Disorders

Seaside Therapeutics, Inc.32 participantsStarted Feb 2010

Phoenix, Arizona, United States • Los Angeles, California, United States • New Haven, Connecticut, United States +5 more locations

COMPLETEDPhase 2< 1 mile

Safety and Efficacy of Once-daily Oral Administrations of TZP-102 for Gastroparesis in Patients With Diabetes Mellitus

NCT00889486

The purpose of this study is to evaluate the effect of TZP-102 on gastric emptying rate, gastroparesis symptoms and health-related quality of life in diabetic patients with gastroparesis.

GastroparesisDiabetes Mellitus

Tranzyme, Inc.92 participantsStarted Apr 2009

Long Beach, California, United States • Los Angeles, California, United States • San Francisco, California, United States +20 more locations

An Open Label Extension Study of STX209 in Subjects With Autism Spectrum Disorders

Safety and Efficacy of Once-daily Oral Administrations of TZP-102 for Gastroparesis in Patients With Diabetes Mellitus

Find Trials by Condition in Los Angeles

Phase I/II Safety Study of IPI-504 in Relapsed/Refractory Stage IIIb, or Stage IV Non-small Cell Lung Cancer (NSCLC)

NUCYNTA (Tapentadol Immediate Release) Versus Oxycodone Immediate Release in the Treatment of Acute Low Back Pain

The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer

Effectiveness of Pacemaker With Closed Loop Stimulation Compared to Pacemakers With and Without Standard Rate Response

Influence of Public Parks on Physical Activity Levels of Diverse Communities

Study of Lornoxicam or Placebo for Acute Treatment of the Headache of Migraine.

Plasm Gastrin Concentrations in Response to Nexium Administration in Healthy Volunteers

Trial of Three Neonatal Antiretroviral Regimens for Prevention of Intrapartum HIV Transmission

A Study of the Effects of RoActemra/Actemra on Vaccination in Patients With Rheumatoid Arthritis on Background Methotrexate (VISARA)

Study of Lornoxicam or Ketorolac or Placebo for Post-Operative Pain After Bunionectomy

Effectiveness and Safety of 3 Dosing Regimens of CP-690,550 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

The Safety and Effectiveness of FIAC in the Treatment of Cytomegalovirus (CMV) in Patients With AIDS

Screening for Early Evidence of Diabetes

A 12-week Study of 4 Doses of VX-509 in Subjects With Active Rheumatoid Arthritis

Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia

Observational Evaluation of the Peristomal Skin Condition in Ostomates

A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVax™-JE and JE-VAX

Study of Citicoline for the Treatment of Traumatic Brain Injury (COBRIT)